2020 Annual Conference

New Orleans

Welcome

Dr. Barry Rosen

Keynote Lecture: TARGIT - A Update

Dr. Jayant Vaidya

Session I: Data Supporting IORT

An Introduction to the TARGIT Quality Collaborative Prospective Registry

Dr. Dennis Holmes

TARGIT - B Update

Dr. Jayant Vaidya

Update of the ExBRT 50KV IORT Multi-Center Registry Study

Dr. Sadia Khan

Session I Q&A

Session II: Non-Breast IORT

Intro

Dr. William Small, Jr.

INTRAGO Trial Update

Dr. Frank Giordano

IORT for Primary and Secondary Brain Tumors

Dr. Ehsan Balagamwala

IORT for Unstable Spine Metastasis

Dr. William Small, Jr.

IORT in Lower GI Malignancies

Dr. Sudha Amarnath

Session III: Oral Abstracts

Intro

Dr. Valery Uhl

Single-institution Evaluation of Local Recurrence Rates Following Intraoperative Radiation Therapy for Breast Cancer

Sarah Schrup

Dosimetric Evaluation and Use of Shielding Materials for Critical Organ Protection in 50 kV Intrabeam Intraoperative Radiation Therapy (IORT)

Dr. Samuel Trichter

Long-term Outcomes for Patients with DCIS Treated with Breast Conservation and Intro-operative Radiotherapy only or Combined with Adjuvant External Beam Radiotherapy

Ms. Kasey Leigh Wood

National Trends for Intra-Operative Radiation Therapy in Favorable, Early Stage Breast Cancer: A Propensity Scoring Analysis of the National Cancer Database

Dr. Mohamad Sebai

Breast IORT in Patients with an Ipsilateral Pacemaker

Dr. Valery Uhl

Utility of Taking Additional Margins when Preforming Breast Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer

Dr. Kristy Broman

Clinical Implementation of a Treatment Planning System Used of INTRABEAM IORT

Dr. Sebastien Gros

Session IV: Biology of IORT

Presidential Address

Dr. Dennis Holmes

TARGIT A & E and Beyond: The Perspective from Radiation Oncology and Biology & How to Establish TARGIT into National Guidelines

Dr. Frederik Wenz

The Rationale Behind Radiobiological Effectiveness, Immune Effects, and Why Immediacy Matters

Dr. Frederik Wenz

Concurrent IORT with Pembrolizumab

Dr. Eileen Connolly

DCIS Trial

Dr. Eileen Connolly